Wimbledon man reviews new Cystic Fibrosis treatment

NHS has commissioned a new cystic fibrosis inhaler.

Sufferers who have to take tobramycin as part of their daily treatment, could now have the choice of taking it as a powder as well as a liquid.

It means the condition could be treated half an hour quicker each day.

The pod-inhaler gives patients a powered version of Tobramycin, which is usually taken as a liquid.

41 year old, Tim Wooton, from Wimbledon, suffers from Cystic Fibrosis, he explained what the new medication is like: "Well it's quicker, which means it's easier for starters."

"There is a skill with getting it right."

"When you first inhale one of the capsules, there is a kick back, which makes you cough, so you have to persist."

"There are four separate capsules you have to inhale via this device every morning and evening."

Cystic Fibrosis is an inherited disease whereby a faulty gene causes irregularity with the water and salt content in the body.

It affects internal organs such as the lungs and the digestive system with the build up of thick mucus.